Fertility and endocrine effects of intra-abdominally misplaced intrauterine system for more than 2 years: A case report and review of the literature

Human Fertility

Volumn 12, Issue 2, 2009, Pages 119-121

  Botros, George ^a   Haddad, Nabil ^a  

^a Countess of Chester O and G ^*  (United Kingdom)

Author keywords

Contraceptive use; Ectopic pregnancy; Fertility

Indexed keywords

CONTRACEPTIVE AGENT; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; AMENORRHEA; CASE REPORT; DEVICE REMOVAL; ENDOCRINE FUNCTION; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; HUMAN; HYSTEROSCOPY; INTRAUTERINE CONTRACEPTIVE DEVICE; INTRAUTERINE SYSTEM MISPLACEMENT; OMENTUM; OUTCOME ASSESSMENT; PERITONEAL CAVITY; SHORT SURVEY; UTERUS; X RAY FILM; ARTICLE; ECTOPIC PREGNANCY; PREGNANCY;

CONTRACEPTIVES, ORAL, SYNTHETIC; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; PREGNANCY; PREGNANCY, ECTOPIC; YOUNG ADULT;

EID: 70350506019     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.1080/14647270902725505     Document Type: Short Survey

References (11)

1. Andersson, K., Odlind, V., & Rybo, G. (1994). Levonorgestrelreleasing and copper-releasing (Nova-T) IUDs during five years of use: a randomized comparative trial. Contraception, 49, 56-72.
2. Bobrow, C., Cooling, H., & Bisson, D. (2000). Amenorrhoea despite displaced levonorgestrel intra-uterine system: a case report. British Journal of Family Planning, 26, 105-106.
3. Grimes, D., Schulz, K., van Vliet, H., & Stanwood, N. (2001). Immediate post-partum insertion of intrauterine devices. Cochrane Database of Systematic Reviews, Issue 2. Art no.: CD003036.
4. Haimov-Kochman, R., Doviner, C., Amsalem, H., Prus, D., Adoni, A., & Lavy, Y. (2003a). Intraperitoneal levonorgestrelreleasing intrauterine device following uterine perforation: the role of progestins in adhesion formation. Human Reproduction, 18, 990-993.
5. Haimov-Kochman, R., Amsalem, H., Adoni, A., Lavy, Y., & Spitz, I. M. (2003b). Management of a perforated levonorgestrel- medicated intrauterine device - a pharmacokinetic study: case report. Human Reproduction, 18, 1231-1233.
6. Harrison-Woolrych, M., Ashton, J., & Coulter, D. (2003). Uterine perforation on intrauterine device insertion: Is the incidence higher than previously reported? Contraception, 67, 53-56.
7. Jonsson, B., Landgren, B. M., & Eneroth, P. (1991). Effects of various IUD's on the composition of cervical mucus. Contraception, 43, 447-458.
8. Leiras Oy. (1995). Mirena product monograph. Turku, Finland. Mirena (levonorgestrel-releasing intrauterine system). Product information. Montville, N.J.: Berlex, 2004. Accessed online June 28, 2008, at: http://www.berlex.com/ html/products/pi/ Mirena-PI.pdf
9. Nilsson, C. G., Lähteenmäki, P. L., & Luukkainen, T. (1984). Ovarian function in amenorrheic and menstruating users of levonorgestrel releasing intrauterine device. Fertility and Sterility, 41, 52-55.
10. Van Houdehoven, K., van Kaam, K., Van Grootheest, A., Salemans, T., & Dunselman, G. (2006). Uterine perforation in women using a Levonorgestrel- releasing intrauterine system. Contraception, 73, 257-260.
11. Zhou, L., Harrison-Woolrych, M., & Coulter, D. M. (2003). Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiol Drug Safety, 12, 371-377.